Landkind announces GRAS status for biosynthesized salidroside
Landkind delivers cognitive function boost with GRAS-approved pure salidroside supplement
2022: The year of acceleration
Landkind Reaches Significant Regulatory Milestone, achieving GRAS Status for LK-01 Pure Salidroside
Double Rainbow ramps up production of ancient natural painkiller
Double Rainbow Announces World’s First Commercial-Scale Biosynthetic Gastrodin, a Natural Analgesic with a Range of Therapeutic Applications
NutraCast: Utilizing synthetic biology to preserve medicinal plants
DoubleRainbow Biosciences and Landkind to Participate in SupplySide West Conference October 31 - November 4
Double Rainbow Announces Membership with BioMADE
Big Pharma’s Green Ambitions
Kelai pens Double Rainbow pact to pair drug delivery and biosynthesis tech
DoubleRainbow Biosciences and Kelai Pharmaceuticals to collaborate on novel natural compound therapeutics
